U.S. market Closed. Opens in 7 hours 44 minutes

INVO | INVO Bioscience, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 0.8171 - 0.8800
52 Week Range 0.6300 - 3.50
Beta 3.00
Implied Volatility 529.98%
IV Rank 77.47%
Day's Volume 124,018
Average Volume 1,176,580
Shares Outstanding 3,906,070
Market Cap 3,253,756
Sector Healthcare
Industry Medical - Devices
IPO Date 2020-11-02
Valuation
Profitability
Growth
Health
P/E Ratio 1.21
Forward P/E Ratio N/A
EPS 0.69
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 25
Country USA
Website INVO
INVO Bioscience, Inc., a commercial-stage fertility company, provides assisted reproductive technology solutions worldwide. Its flagship product is the INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.
*Chart delayed
Analyzing fundamentals for INVO we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is frighteningly weak. For more detailed analysis please see INVO Fundamentals page.

Watching at INVO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on INVO Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙